HSV-1 DNA Replication-Coordinated Regulation by Viral and Cellular Factors

被引:33
|
作者
Packard, Jessica E. [1 ]
Dembowski, Jill A. [1 ]
机构
[1] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA
来源
VIRUSES-BASEL | 2021年 / 13卷 / 10期
关键词
herpes simplex virus; HSV-1; DNA replication; replication fork; recombination; SIMPLEX-VIRUS TYPE-1; ORIGIN-BINDING-PROTEIN; HERPESVIRUS MACROMOLECULAR-SYNTHESIS; MISMATCH REPAIR PROTEINS; HELICASE-PRIMASE; NUCLEAR ANTIGEN; POLYMERASE PROCESSIVITY; CATALYTIC SUBUNIT; ALKALINE NUCLEASE; THYMIDINE KINASE;
D O I
10.3390/v13102015
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
DNA replication is an integral step in the herpes simplex virus type 1 (HSV-1) life cycle that is coordinated with the cellular DNA damage response, repair and recombination of the viral genome, and viral gene transcription. HSV-1 encodes its own DNA replication machinery, including an origin binding protein (UL9), single-stranded DNA binding protein (ICP8), DNA polymerase (UL30), processivity factor (UL42), and a helicase/primase complex (UL5/UL8/UL52). In addition, HSV-1 utilizes a combination of accessory viral and cellular factors to coordinate viral DNA replication with other viral and cellular processes. The purpose of this review is to outline the roles of viral and cellular proteins in HSV-1 DNA replication and replication-coupled processes, and to highlight how HSV-1 may modify and adapt cellular proteins to facilitate productive infection.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Hsv/aav hybrid amplicon vectors:: Is AAV rep expression compatible with efficient HSV-1 DNA replication?
    Fraefel, C
    Baechi, T
    Bittermann, AG
    Meyer, C
    Heister, T
    Ackermann, M
    CANCER GENE THERAPY, 2004, 11 (12) : 845 - 845
  • [32] Risk factors of herpes simplex type 1 (HSV-1) infection and lifestyle factors associated with HSV-1 manifestations
    Christiane Stock
    Francisco Guillén-Grima
    Juan Hermoso de Mendoza
    Blanca Marin-Fernandez
    Ines Aguinaga-Ontoso
    Alexander Krämer
    European Journal of Epidemiology, 2001, 17 : 885 - 890
  • [33] Psoromic Acid, a Lichen-Derived Molecule, Inhibits the Replication of HSV-1 and HSV-2, and Inactivates HSV-1 DNA Polymerase: Shedding Light on Antiherpetic Properties
    Hassan, Sherif T. S.
    Sudomova, Miroslava
    Berchova-Bimova, Katerina
    Smejkal, Karel
    Echeverria, Javier
    MOLECULES, 2019, 24 (16):
  • [34] PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE AS A POTENT INHIBITOR OF HSV-1 REPLICATION
    KIMURA, T
    HOTTA, Y
    SADO, K
    KATO, T
    SAKUMA, H
    KANAI, A
    KONNO, K
    SHIGETA, S
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (04) : 787 - 787
  • [35] Inhibition of HSV-1 replication by a gene editing strategy
    Bellizzi, Anna
    Wollebo, Hassen S.
    Caocci, Maurizio
    De Chiara, Giovanna
    Palamara, Anna T.
    Gordon, Jennifer
    Khalili, Kamel
    JOURNAL OF NEUROVIROLOGY, 2018, 24 : S5 - S5
  • [36] Human lactoferrin but not lysozyme neutralizes HSV-1 and inhibits HSV-1 replication and cell-to-cell spread
    Hannamari Välimaa
    Jorma Tenovuo
    Matti Waris
    Veijo Hukkanen
    Virology Journal, 6
  • [37] Human lactoferrin but not lysozyme neutralizes HSV-1 and inhibits HSV-1 replication and cell-to-cell spread
    Valimaa, Hannamari
    Tenovuo, Jorma
    Waris, Matti
    Hukkanen, Veijo
    VIROLOGY JOURNAL, 2009, 6
  • [38] Inhibition of HSV-1 replication by a gene editing strategy
    Bellizzi, Anna
    Wollebo, Hassen S.
    Caocci, Maurizio
    De Chiara, Giovanna
    Palamara, Anna T.
    Gordon, Jennifer
    Khalili, Kamel
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2018, 13 : S5 - S5
  • [39] Risk factors of herpes simplex type 1 (HSV-1) infection and lifestyle factors associated with HSV-1 manifestations
    Stock, C
    Guillén-Grima, F
    de Mendoza, JH
    Marin-Fernandez, B
    Aguinaga-Ontoso, I
    Krämer, A
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2001, 17 (09) : 885 - 890
  • [40] Deciphering AAV replication strategy in the presence of HSV-1
    Nicolas, A.
    Alazard-Dany, N.
    Biollay, C.
    Arata, L.
    Jolinon, N.
    Kuhn, L.
    Ferro, M.
    Weller, S. K.
    Epstein, A. L.
    Greco, A.
    Salvetti, A.
    HUMAN GENE THERAPY, 2010, 21 (10) : 1397 - 1397